DB Wealth Management Group’s Novavax NVAX Stock Holding History

DB Wealth Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-400	Closed	-$2.9K	–	380
2023 Q3	$2.9K	Hold	400	–	–	﹤0.01%	333
2023 Q2	$2.97K	Hold	400	–	–	﹤0.01%	333
2023 Q1	$2.77K	Hold	400	–	–	﹤0.01%	330
2022 Q4	$4.11K	Buy	+400	New	+$7.06K	﹤0.01%	309
2022 Q3	–	Sell	-400	Closed	-$21K	–	294
2022 Q2	$21K	Hold	400	–	–	0.01%	234
2022 Q1	$29K	Buy	400 +200	+100%	+$17.8K	0.02%	215
2021 Q4	$29K	Buy	+200	New	+$34.4K	0.02%	208

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DB Wealth Management Group's NVAX Position: Q4 2023 in Review

DB Wealth Management Group sold out of Novavax (NVAX) in Q4 2023, closing a stake of 400 shares — an estimated $2.9K sold.

DB Wealth Management Group first reported a position in NVAX in Q4 2021 and held it in 7 quarters. The position peaked at $29K in Q1 2022. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

DB Wealth Management Group reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
DB Wealth Management Group sold 400 Novavax shares in Q4 2023, an estimated $2.9K.
DB Wealth Management Group first reported a position in Novavax in Q4 2021 and held it in 7 quarters.
DB Wealth Management Group's Novavax position peaked at $29K in Q1 2022.
199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.